Iron, ascorbate and copper status of Sowetan Blacks with calcific chronic pancreatitis

QJM: An International Journal of Medicine

Volumn 89, Issue 1, 1996, Pages 45-53

  Segal, I ^a   Sharer, N M ^b   Kay, P M ^b   Gutteridge, J M C ^c   Braganza, J M ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CERULOPLASMIN; COPPER; FERRITIN; IRON;

ADOLESCENT; ADULT; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; NEGRO; OXIDATIVE STRESS; PANCREAS CALCIFICATION; PRIORITY JOURNAL; SOUTH AFRICA; UNITED KINGDOM;

EID: 0030040732     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.qjmed.a030136     Document Type: Article

References (47)

1. Uden S, Bilton D, Nathan L, Hunt LP, Main C, Braganza JM. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trials. Aliment Pharmacol Ther 1990; 4:357-71.
2. Uden S, Schofield D, Miller PF, Day JP, Bottiglieri T, Braganza JM. Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther 1992; 6:229-40.
3. Braganza JM. Antioxidant therapy for pancreatitis: clinical experience. In: Braganza JM, ed. The Pathogenesis of Pancreatitis. Manchester, Manchester University Press, 1991:178-97.
4. Whiteley G, Kienle A, Lee S, Taylor P, Schofield D, Braganza J, McCloy R. Micronutrient antioxidant therapy in the non-surgical management of painful chronic pancreatitis: long-term observations. Pancreas 1994; 9(suppl):A807.
5. Bilton D, Schofield D, Mei G, Kay PM, Bottiglieri T, Braganza JM. Placebo-controlled trials of antioxidant therapy including S-adenosylmethionine in patients with recurrent non-gallstone pancreatitis. Drug Invest 1994; 8:10-20.
6. Segal I, Lerios M, Grieve T. The emergence of chronic calcific pancreatitis in a developing country. In: Gyr KE, Singer MV, Sarles H, eds. Pancreatitis: concepts and classifications. Amsterdam, Excerpta Medica, 1984:417-20.
7. Segal I, Lerios M, MacPhail AP, Bisceglie AM, Grieve TP. The genesis of chronic pancreatitis in the South African black population. S Afr Med J 1988; 74:385-6.
8. Strachan AS. Haemosiderosis and haemochromatosis in south African natives with a comment on the aetiology of haemochromatosis. MD Thesis, Glasgow, 1929.
9. Gillman J, Mandelstam J, Gillman T. Comparison of chemical and histological estimations of the iron and copper content of the livers of Africans in relation to the pathogenesis of cytosiderosis and cirrhosis (haemochromatosis). South African J M Sc 1945; 10:109-36.
10. Walker ARP, Arvidsson UB. 'Iron overload' in the south African Bantu. Tr Roy Soc Trop Med Hyg 1953; 47:536-40.
11. Seftel HC, Malkin C, Schmaman C, Abrahams C, Lynch SR, Charlton RW, Bothwell TH. Osteoporosis, scurvy, and siderosis in Johannesburg Bantu. Br Med J 1966; 1:642-6.
12. Bothwell TH, Charlton RW, Cook JD, Finch CA, eds. Iron metabolism in man. Oxford, Blackwell Scientific Publications, 1979.
13. Cohen A, Cohen IJ, Schwartz E. Scurvy and altered iron stores in thalassaemia major. N Engl J Med 1981; 304:158-60.
14. Nienhuis AW. Vitamin C and iron. N Engl J Med 1981; 304:170-1.
15. Gut A, Shiel N, Kay PM, Segal I, Braganza JM. Heightened free radical activity in blacks with chronic pancreatitis at Johannesburg, south Africa. Clim Chim Acta 1994; 230:189-99.
16. Chaloner C, Segal I, Hassan H, McIntosh J, Gut A, Rahme M, Braganza JM. A preliminary report of urinary BT-PABA/PAS excretion index, serum pancreatic isoamylase and faecal chymotrypsin tests of pancreatic dysfunction in Sowetan Africans. Clim Chim Acta 1995; 233:89-99.
17. Gut A, Chaloner C, Schofield D, Sandle LR Purmasir M, Segal I, Braganza JM. Evidence of toxic metabolite stress in black South Africans with chronic pancreatitis. Clin Chim Acta 1995; 236:145-53.
18. Segal I, Gut A, Schofield D, Shiel N, Braganza JM. Micronutrient antioxidant status in black South Africans with chronic pancreatitis: opportunity for prophylaxis. Clim Chim Acta 1995; 239:71-9.
19. Segal I, Braganza JM, Gut A, Ally R, Maberti P, Mokoena L, Van't Hoff A, Beer M De. Alcohol, nutritional factors and occupational xenobiotics in chronic calcific pancreatitis: a case-controlled study. S Afr Med J 1993; 83 (suppl):A780.
20. Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 1974; 290:1213-16.
21. Gutteridge JMC, Paterson SK, Segal AW, Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem J 1981; 199:259-61.
22. Halliwell B. How to characterise a biological antioxidant. Free Rad Res Commun 1990; 9:1-32.
23. Gutteridge JMC, Quinlan GJ. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron oxidising proteins. Biochim Biophys Acta 1992; 19:248-54.
24. Gutteridge JMC, Halliwell B. Transition metal ions and antioxidant proteins in extracellular fluids. In: Scott G, ed. Atmospheric Oxidation and Antioxidants, vol III. Amsterdam, Elsevier, 1993:71-99.
25. Balla C, Jacob HS, Balla J, Rosenburg M, Nath K, Apple F, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective antioxidant stratagem of endothelium. J Biol Chem 1992; 267:18148-53.
26. Braganza JM, Schofield D, Snehalatha C, Mohan V. Micronutrient antioxidant status in tropical compared to temperate-zone pancreatitis. Scand J Gastroenterol 1993; 28:1098-104.
27. Bell M, Jamison M, Braganza JM. Serum copper oxidase activity (caeruloplasmin) in chronic pancreatitis: inverse correlation with pancreatic exocrine function. Clin Chim Acta 1981; 117:259-69.
28. Hunt LP, Braganza JM. On optimising the diagnostic yield of secretin pancreazymon tests. Clim Chim Acta 1989; 186:91-108.
29. Uden S, Acheson DWK, Reeves J, Worthington HV, Hunt LP, Brown S, Braganza JM. Antioxidants, enzyme induction and chronic pancreatitis: a reappraisal following studies in patients on anticonvulsants. Eur J Clin Nutr 1988; 42:561-70.
30. Pezzilli R, Billi P, Melandri R, Broccoli PL, Fontana G. Anticonvulsant induced chronic pancreatitis. A case report. Ital J Gastroenterol 1992; 24:245-6.
31. McNamee R, Braganza JM, Hogg J, Leek I, Cherry N. Occupational hydrocarbons and chronic pancreatitis: a case-referent study. Occup Environ Med 1994; 51:631-7.
32. Gutteridge JMC. Bleomycin-iron in biological fluids. What does the assay measure? In: Rice-Evans C, Halliwell B. eds. Free radicals: methodology and concepts. Richelieu Press, London, 1988:429-69.
33. Gutteridge JMC. Copper-phenanthroline induced site specific oxygen radical damage to DNA. Detection of loosely-bound trace copper in biological fluids. Biochem J 1984; 218:983-5.
34. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. Low molecular weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci. 1985; 68:463-9.
35. Seiss H, ed. Oxidative Stress. London, Academic Press, 1985.
36. Braganza JM. Toxicology of the pancreas. In: Ballantyne B, Turner P, Marrs TC, eds. Textbook of General and Applied Toxicology. New York, MacMillan, 1993:663-714.
37. Johnson DA, Osaki S, Frieden E. A micromethod for the determination of ferroxidase (caeruloplasmin) in human serums. Clin Chem 1967; 12:142-50.
38. Gutteridge JMC, Winyward P, Blake DR, Lunec J, Brailsford S, Halliwell B. The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline detectable copper. Biochem J 1985; 230:517-23.
39. Gutteridge JMC, Quinlan GJ, Mumby S, Heath A, Evans TW. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidising, iron-binding and free radical scavenging proteins. J Lab Clin Med 1994; 124:263-73.
40. MacPhail AP, Simon MO, Torrance JD, Charlton RW, Bothwell TH, Isaacson C. Changing patterns of dietary iron-overload in black South Africans. Am J Clin Nutr 1979; 32:1272-8.
41. Basso D, Panozzo MP, Plebani M, Meggiato T, Zaninotto M, Piccoli A, Fogar P, Ferrara C, Del Favero G, Burlina A. Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship? J Med 1994; 25:91-104.
42. Cawley T. A singular case of diabetes, consisting entirely in the quality of the urine; with an enquiry into the different theories of the disease. London Med J 1788; 9:286-308.
43. Higginson J, Keeley KG, Anderson M, Walker ARP. Serum iron levels in siderosis due to habitually excessive iron intake. J Clin Invest 1957; 36:1723-5.
44. Hathorn M, Gillman T, Canham PAS, Lamont NP. Plasma iron and iron-binding capacity in African males with siderosis. Clin Sci 1960; 19:35-43.
45. Goldberg L, Smith JP. Iron-overloading and hepatic vulnerability. Am J Path 1960; 36:125-49.
46. Powers HJ, Loban A, Silvers K, Gibson AT Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin. Free Rad Res Commun 1995; 22:57-65.
47. Sharer NM, Taylor PM, Linaker BD, Gutteridge JMC, Braganza JM. Safe and successful use of vitamin C to treat painful calcific chronic pancreatitis despite iron overload from primary haemochromatosis. Clin Drug Invest 1995; 10(5): 310-15.